Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (1y) (2010 - 2018)
Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (1y) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.93 Bn | 32.19 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.55 Bn | 30.61 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | 0.40% |
| 5 | United Therapeutics | 23.08 Bn | 20.92 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | -2.58% |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.41 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -96.53% |
| Dec 31, 2017 | -74.86% |
| Sep 30, 2017 | -63.82% |
| Jun 30, 2017 | 11.29% |
| Mar 31, 2017 | 12.70% |
| Dec 31, 2016 | 19.31% |
| Sep 30, 2016 | 18.47% |
| Jun 30, 2016 | 7.64% |
| Mar 31, 2016 | 5.86% |
| Dec 31, 2015 | 6.62% |
| Sep 30, 2015 | -2.38% |
| Jun 30, 2015 | -3.68% |
| Mar 31, 2015 | -0.34% |
| Dec 31, 2014 | -1.45% |
| Sep 30, 2014 | 11.36% |
| Jun 30, 2014 | 11.57% |
| Mar 31, 2014 | 3.56% |
| Dec 31, 2013 | 28.97% |
| Sep 30, 2013 | 11.39% |
| Jun 30, 2013 | 16.52% |